Cargando…
Manidipine–delapril combination in the management of hypertension
High blood pressure (BP) is the major cardiovascular risk factor and the main cause of death around the world. Control of blood pressure reduces the high mortality associated with hypertension and the most recent guidelines recommend reducing arterial BP values below 140/90 mmHg for all hypertensive...
Autor principal: | Luque Otero, Manuel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293964/ https://www.ncbi.nlm.nih.gov/pubmed/17703633 |
Ejemplares similares
-
Dissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine()
por: Todeschini, Vítor, et al.
Publicado: (2016) -
Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysis
por: Circelli, Maria, et al.
Publicado: (2012) -
Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness
por: Lee, Heejin, et al.
Publicado: (2020) -
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes
por: SaizSatjes, Margarita, et al.
Publicado: (2018) -
PCL/PHBV Microparticles as Innovative Carriers for Oral Controlled Release of Manidipine Dihydrochloride
por: Barboza, Fernanda Malaquias, et al.
Publicado: (2014)